Alendronate Sodium Tablets

Award Notice Posted

Solicitation number
SPE2D2-26-D-0009
Agency
Awarded
to Exelan Pharmaceuticals Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
SPE2D2-26-D-0009 Federal IDV award
Place of performance
Piscataway, New Jersey 08854, United States

Notice details come from SAM.gov. Updated .

About this opportunity

Written by GovTribe AI ·

The Defense Logistics Agency Troop Support Medical awarded contract SPE2D2-26-D-0009 to Exelan Pharmaceuticals, Inc. on March 19, 2026, for the supply of Alendronate Sodium tablets in two formulations: 35 MG and 70 MG tablets in 4-count boxes. The contract has an estimated total value of $4,457,450.00 and will operate over a five-year period consisting of a base year plus four option years, with unit pricing set at $2.00 per box for both pharmaceutical products. The awarded contract was solicited under SPE2D2-25-R-0023, which was originally issued on September 23, 2025, and closed on November 3, 2025. These pharmaceutical supplies are designated exclusively for Department of Defense and Indian Health Service demand, with Exelan Pharmaceuticals utilizing APPCO Pharma LLC as the manufacturer and Nutra-Med Packaging Inc. for packaging and packing services.

Notice text

Award for Alendronate Sodium Tablets solicited under SPE2D2-25-R-0023.

Awarded contract SPE2D2-26-D-0009 to EXELAN PHARMACEUTICALS INC for 4457450.00 on 2026-03-19.

Files

File Type Posted
Award Document - SPE2D2-26-D-0009 - Alendronate Sodium - Bi-Laterally Signed.pdf PDF

Notice history

Notice Type Posted
This notice Award Award Notice
Alendronate Sodium Tablets Latest solicitation Solicitation
Alendronate Sodium Tablets Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity
Try for free Login